To monitor the health of patients undergoing or recovering from heart surgery, the Coração Institute at the University of São Paulo Faculty of Medicine (InCor) Hospital is supposed to manufacture the Galaxy Watch 4 from Samsung, which can be used by certain individuals. The experiment was sponsored by a Korean technology company.
Initially, the project involving cardiac patients should last 14 months and will test assisted digital telemonitoring in practice. Volunteers will share different clinical signs, such as the strength of their heartbeat, by using the smartwatch.
Who should use the Galaxy Watch 4 in an experiment?
According to the research announcement, the Galaxy Watch 4 will be worn by patients before and after surgery. Among the vital signs collected, the person in charge of the experiment emphasized:
Through the monitoring of these data, it will be possible to identify possible risks to the patient’s health. For example, if any relevant changes occur, the medical team might intervene early and invite users for a series of tests. Therefore, more serious complications should be avoided.
How to monitor patient information?
The information captured by the smartwatch must be stored on a highly secure data platform developed by InCor’s medical, multi-professional, technical and innovation teams, including InovaInCor.
In the process, Samsung will play a role in the data acquisition module of the smartwatch for research purposes. The module was developed by Samsung Brazil’s R&D department in Campinas, inland of São Paulo.
What are the prospects for working with hospitals?
According to the Brazilian Society of Cardiovascular Surgery (Sbccv), more than 100,000 heart surgeries are performed each year in Brazil, which deserves an explanation. In other words, if the results are encouraging, the potential demand for such monitoring could be high.
One of the potential benefits, as explained by Fabio Jatene, chief physician of cardiovascular surgery at InCor, is a shorter hospital stay after surgery, as patients will continue to be monitored at home.
“We have taken an innovative step in medicine that we hope will go a long way toward delivering health value to patients and significantly improving their care experience,” Jatene said in a statement.
“The purpose of this research project is to allow patients to be assisted with data collected through the Galaxy Watch, with appropriate prior authorization. The platform will allow them to continue to be monitored during treatment, even outside the hospital setting, helping to identify possible risk situations and take preventive medical actions”, emphasizes Luis Guilherme Selber, Innovation Manager, R&D Area, Samsung Brazil.
Although this watch and other similar models are functional, it should be noted that the information generated is for general health and physical activity purposes only. In this way, measurements should not be used to end a diagnosis or define medical care, but they can serve as a way to screen for possible complications.